Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Analytical Chemistry|July 11, 2014
Generic automated method for liquid chromatography-multiple reaction monitoring mass spectrometry based monoclonal antibody quantitation for preclinical pharmacokinetic studiesQian Zhang, Daniel S Spellman, Yaoli Song, et al.
Pharmacogenetics and Genomics|May 19, 2006
N-Acetyltransferase and sulfotransferase activity in human prostate: potential for carcinogen activationSalah Z Al-Buheissi, Hiten R Patel, Walter Meinl, et al.
Plos Biology|November 9, 2021
Correction: Extracellular phosphorylation of a receptor tyrosine kinase controls synaptic localization of NMDA receptors and regulates pathological painKenji Hanamura, Halley R Washburn, Sean I Sheffler-Collins, et al.
Plos Biology|July 19, 2017
Extracellular phosphorylation of a receptor tyrosine kinase controls synaptic localization of NMDA receptors and regulates pathological painKenji Hanamura, Halley R Washburn, Sean I Sheffler-Collins, et al.
Proteomics. Clinical Applications|February 14, 2015
Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSFDaniel S Spellman, Kristin R Wildsmith, Lee A Honigberg, et al.
Journal of the American Society for Mass Spectrometry|July 12, 2024
Leveraging High-Resolution Ion Mobility-Mass Spectrometry for Cyclic Peptide Soft Spot IdentificationMaria Fawaz, Congliang Sun, Yu Feng, et al.
BJU International|November 16, 2004
A pilot randomized double-blind placebo-controlled trial on the use of antibiotics on urinary catheter removal to reduce the rate of urinary tract infection: the pitfalls of ciprofloxacinHassan D Wazait, Hitenddra R Patel, Jan H P van der Meulen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2021
Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's diseaseOndrej Libiger, Leslie M Shaw, Mark H Watson, et al.
Vaccine|September 30, 2023
Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adultsJesse Nussbaum, Xin Cao, Radha A Railkar, et al.
Human Vaccines & Immunotherapeutics|October 30, 2020
A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adultsAntonios O Aliprantis, Christine A Shaw, Paul Griffin, et al.
Pageof 5